H.A. Peredo

623 total citations
47 papers, 508 citations indexed

About

H.A. Peredo is a scholar working on Physiology, Endocrinology, Diabetes and Metabolism and Biochemistry. According to data from OpenAlex, H.A. Peredo has authored 47 papers receiving a total of 508 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Physiology, 16 papers in Endocrinology, Diabetes and Metabolism and 15 papers in Biochemistry. Recurrent topics in H.A. Peredo's work include Nitric Oxide and Endothelin Effects (18 papers), Eicosanoids and Hypertension Pharmacology (15 papers) and Diet, Metabolism, and Disease (11 papers). H.A. Peredo is often cited by papers focused on Nitric Oxide and Endothelin Effects (18 papers), Eicosanoids and Hypertension Pharmacology (15 papers) and Diet, Metabolism, and Disease (11 papers). H.A. Peredo collaborates with scholars based in Argentina, El Salvador and Chile. H.A. Peredo's co-authors include Enri Borda, Ana M. Puyó, Edda Adler‐Graschinsky, Marcos Mayer, Luis A. Boerr, Zulema Kogan, Alicia M. Sambuelli, María Amelia Enero, Emilia Sugai and Jie Bai and has published in prestigious journals such as Gastroenterology, Life Sciences and European Journal of Pharmacology.

In The Last Decade

H.A. Peredo

46 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H.A. Peredo Argentina 14 151 141 134 122 96 47 508
Priska Stahel Canada 14 154 1.0× 61 0.4× 209 1.6× 36 0.3× 143 1.5× 29 514
Won Kyoo Cho United States 14 114 0.8× 318 2.3× 149 1.1× 34 0.3× 213 2.2× 29 789
Panagiotis Giannogonas Greece 6 206 1.4× 152 1.1× 42 0.3× 30 0.2× 39 0.4× 6 548
Oscar R. Rebolledo Argentina 13 170 1.1× 100 0.7× 221 1.6× 38 0.3× 151 1.6× 33 506
A Ciccolo Italy 11 127 0.8× 55 0.4× 21 0.2× 62 0.5× 171 1.8× 25 609
Yvonne Oligschlaeger Netherlands 15 101 0.7× 223 1.6× 62 0.5× 45 0.4× 109 1.1× 28 546
Mechteld Grootte Bromhaar Netherlands 5 259 1.7× 154 1.1× 68 0.5× 73 0.6× 69 0.7× 5 642
Erika Tirotta Italy 11 87 0.6× 78 0.6× 28 0.2× 51 0.4× 74 0.8× 13 425
P. Ashby United Kingdom 11 179 1.2× 58 0.4× 118 0.9× 44 0.4× 45 0.5× 12 528
H.-U. Häring Germany 13 110 0.7× 61 0.4× 182 1.4× 56 0.5× 101 1.1× 29 493

Countries citing papers authored by H.A. Peredo

Since Specialization
Citations

This map shows the geographic impact of H.A. Peredo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H.A. Peredo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H.A. Peredo more than expected).

Fields of papers citing papers by H.A. Peredo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H.A. Peredo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H.A. Peredo. The network helps show where H.A. Peredo may publish in the future.

Co-authorship network of co-authors of H.A. Peredo

This figure shows the co-authorship network connecting the top 25 collaborators of H.A. Peredo. A scholar is included among the top collaborators of H.A. Peredo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H.A. Peredo. H.A. Peredo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Peredo, H.A., et al.. (2018). Efectos del tungstato de sodio y sulfato de vanadilo sobre la liberación de prostanoides del lecho vascular mesentérico de ratas diabéticas. Clínica e Investigación en Arteriosclerosis. 30(6). 249–257. 1 indexed citations
2.
Puyó, Ana M., et al.. (2009). Time course of vascular prostanoid production in the fructose‐hypertensive rat. Autonomic and Autacoid Pharmacology. 29(3). 135–139. 3 indexed citations
3.
Peredo, H.A., Marcos Mayer, Andrea Carranza, & Ana M. Puyó. (2008). Pioglitazone and Losartan Modify Hemodynamic and Metabolic Parameters and Vascular Prostanoids in Fructose-Overloaded Rats. Clinical and Experimental Hypertension. 30(2). 159–169. 14 indexed citations
4.
Peredo, H.A., et al.. (2008). Dehydroepiandrosterone (DHEA) prevents the prostanoid imbalance in mesenteric bed of fructose-induced hypertensive rats. European Journal of Nutrition. 47(7). 349–356. 5 indexed citations
5.
Puyó, Ana M., et al.. (2007). Noradrenaline and angiotensin II modify vascular prostanoid release in fructose‐fed hypertensive rats. Autonomic and Autacoid Pharmacology. 27(4). 161–165. 5 indexed citations
6.
Lemberg, A, et al.. (2007). Enzymatic activities in brains of diabetic rats treated with vanadyl sulphate and sodium tungstate. Acta Physiologica Hungarica. 94(4). 315–319. 2 indexed citations
7.
Peredo, H.A., et al.. (2006). Long‐term streptozotocin‐induced diabetes alters prostanoid production in rat aorta and mesenteric bed. Autonomic and Autacoid Pharmacology. 26(4). 355–360. 23 indexed citations
8.
Puyó, Ana M., et al.. (2004). Fructose overload modifies vascular morphology and prostaglandin production in rats. Autonomic and Autacoid Pharmacology. 24(2). 29–35. 19 indexed citations
9.
Evelson, Pablo, et al.. (2004). DECREASED OXIDATIVE STRESS IN PREHEPATIC PORTAL HYPERTENSIVE RAT LIVERS FOLLOWING THE INDUCTION OF DIABETES. Clinical and Experimental Pharmacology and Physiology. 31(3). 169–173. 6 indexed citations
10.
Peredo, H.A.. (2003). Opposite effects of endogenous nitric oxide and prostaglandin F2α in the rat mesenteric bed. Autonomic and Autacoid Pharmacology. 23(3). 167–172. 4 indexed citations
11.
Peredo, H.A.. (2002). Defibrotide modulates prostaglandin production in the rat mesenteric vascular bed. Prostaglandins Leukotrienes and Essential Fatty Acids. 67(4). 211–216. 2 indexed citations
12.
Peredo, H.A. & Edda Adler‐Graschinsky. (2000). Effects of eicosanoids and nitric oxide on the noradrenaline‐induced contractions in the rat mesenteric bed. Journal of Autonomic Pharmacology. 20(3). 163–170. 14 indexed citations
13.
Peredo, H.A., et al.. (1999). Effect of dipyridamole on prostanoid production in rat isolated atria. Prostaglandins Leukotrienes and Essential Fatty Acids. 60(2). 125–128. 4 indexed citations
14.
Peredo, H.A., et al.. (1999). Time-course of the alterations in prostanoid production and in contractile responses of mesenteric beds isolated from streptozotocin diabetic rats. Prostaglandins Leukotrienes and Essential Fatty Acids. 60(4). 269–274. 13 indexed citations
15.
Peredo, H.A., et al.. (1997). Differential effects of acetylcholine and bradykinin on prostanoid release from the rat mesenteric bed: role of endothelium and of nitric oxide. Prostaglandins Leukotrienes and Essential Fatty Acids. 56(4). 253–258. 12 indexed citations
16.
Boerr, Luis A., Alicia M. Sambuelli, H.A. Peredo, et al.. (1996). Increased mucosal levels of leukotriene B4 in pouchitis. European Journal of Gastroenterology & Hepatology. 8(1). 57–62. 16 indexed citations
17.
Peredo, H.A., et al.. (1994). Prostanoid production in hypoxic rat isolated atria: Influence of acute diabetes. Prostaglandins Leukotrienes and Essential Fatty Acids. 51(4). 231–234. 7 indexed citations
18.
Peredo, H.A. & Enri Borda. (1992). Testosterone stimulates prostanoid production by rat vas deferens. Prostaglandins Leukotrienes and Essential Fatty Acids. 46(4). 311–314. 1 indexed citations
19.
Peredo, H.A., et al.. (1990). Production of thromboxanes by transformed lymphocytes — Effect on heart contractility. International Journal of Immunopharmacology. 12(2). 149–154. 2 indexed citations
20.
Borda, Enri, et al.. (1983). Contractile activity of the isolated rat vas deferens and release of prostaglandin E and F-like substances. Influences of acetylcholine and inhibitors of cyclo-oxygenase and phospholipase A2.. PubMed. 263(2). 245–53. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026